Helicobacter pylori screening and gastric cancer [17]

Lancet

Volumn 348, Issue 9029, 1996, Pages 758-759

  Ponzetto, A ^a   Soldati, T ^a   De Giuli, M ^a   Danesh, J ^a   Forman, D ^a   Collins, R ^a   Peto, R ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PREVENTION; CANCER RISK; CLINICAL PROTOCOL; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; LETTER; PRIORITY JOURNAL; SCREENING; STOMACH CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HELICOBACTER INFECTION; ISOLATION AND PURIFICATION; MASS SCREENING; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; MORTALITY; NOTE; ORGANIZATION AND MANAGEMENT; RANDOMIZED CONTROLLED TRIAL; STOMACH TUMOR; SURVIVAL; UNITED KINGDOM; AGED; COST BENEFIT ANALYSIS; ECONOMICS; INCIDENCE; ITALY; MALE;

GREAT BRITAIN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MASS SCREENING; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; AGED; COST-BENEFIT ANALYSIS; INCIDENCE; ITALY; MALE;

EID: 0029784349     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(05)65672-3     Document Type: Letter

References (2)

1. J Parsonnet RA Harris HM Hack DK Owens Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials Lancet 348 1996 150 154
2. MT Halpern BW Gillespie KE Warner Patterns of absolute risk of lung cancer mortality in former smokers J Nat Cancer Inst 85 1993 457 464